Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Appendix 3B

8 Mar 2013 07:39

RNS Number : 5569Z
Oilex Limited
08 March 2013
 



 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

 

 

Appendix 3B

 

New issue announcement,application for quotation of additional securitiesand agreement

 

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

 

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005, 01/08/2012.

 

 

Name of entity

 OILEX LTD

 

ABN

50 078 652 632

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1.

+Class of +securities issued or to be issued

 

Unlisted options

2.

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

5 million

3.

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and expiring dates for payment; if +convertible securities, the conversion price and dates for conversion)

$0.25 options vesting on 8 March 2014 and expiring on 8 March 2016

 

 

4.

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

·; the date from which they do

·; the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·; the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Not applicable.

 

 

 

5.

Issue price or consideration

 

NIL

 

 

 

6.

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

Options issued for corporate advisory services

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

No

6b

The date the security holder resolution under rule 7.1A was passed

6c

Number of +securities issued without security holder approval under rule 7.1

 

6d

Number of +securities issued with security holder approval under rule 7.1A

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

 

 

6f

Number of securities issued under an exception in rule 7.2

 

 

6g

If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation.

 

 

6h

If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

 

40,212,311

 

7.

Dates of entering +securities into uncertificated holdings or despatch of certificates

 

 

 

8 March 2013

 

 

Number

+Class

8.

Number and +class of all +securities quoted on ASX (including the securities in clause 2 if applicable)

 

 

 

 

354,748,741

 

151,923,069

 

Ordinary Shares

 

Options exercisable at 15 cents expiring 7 September 2015

 

 

  

 

Number

+Class

 

9.

Number and +class of all +securities not quoted on ASX (including the securities in clause 2 if applicable)

 

75,000

4,150,000

8,737,500

75,000

3,000,000

 

3,000,000

 

1,000,000

1,000,000

 

5,000,000

$0.50 Options expiring 01/08/2013

$0.30 Options expiring 01/07/2014

$0.37 Options expiring 10/11/2014

$0.63 Options expiring 01/08/2015

$0.15 Options expiring17/12/2015 (vesting 17/7/13)

$0.25 Options expiring 17/12/2016 (vesting 17/7/14)

$0.15 Options expiring 30/01/2016

$0.25 Options expiring 30/01/2017 (vesting 30/1/14)

$0.25 Options expiring 08/03/2016 (vesting 8/3/14)

 

 

 

 

10.

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

 

 

 

 

 Part 2 ‑ Bonus issue or pro rata issue [Item 11 to 33 - Not Applicable]

 

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of securities

(tick one)

(a)

Securities described in Part 1

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

 

 

Entities that have ticked box 34(a) [Items 35 to 42 - Not Applicable]

Additional securities forming a new class of securities

 

 

 

 

Quotation agreement

 

1. +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2. We warrant the following to ASX.

 

·; The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

·; There is no reason why those +securities should not be granted +quotation.

·; An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

·; Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

·; We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the +securities to be quoted, it has been provided at the time that we request that the +securities be quoted.

·; If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3. We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4. We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

Date: 8 March 2013

 

Print name: Robert Ierace

(Chief Financial Officer / Company Secretary)

 

 

 

  

 

Appendix 3B - Annexure 1

 

Calculation of placement capacity under rule 7.1 and rule 7.1A for +eligible entities

Introduced 01/08/12

 

Part 1

 

Rule 7.1 - Issues exceeding 15% of capital

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

Insert number of fully paid ordinary securities on issue 12 months before date of issue or agreement to issue

253,324,885

Add the following:

• Number of fully paid ordinary securities issued in that 12 month period under an exception in rule 7.2

 

22,004 (issued 21/09/2012)

2,565 (issued 28/12/2012)

49,757 (issued 18/01/2013)

19,576 (issued 18/02/2013)

·; Number of fully paid ordinary securities issued in that 12 month period with shareholder approval

101,329,954 (issued 07/09/2012)

 

• Number of partly paid ordinary

securities that became fully paid in that 12 month period

Nil

 

Note:

• Include only ordinary securities here - other classes of equity securities cannot be added

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

Subtract the number of fully paid ordinary securities cancelled during that 12 month period

Nil

"A"

354,748,741

 

Step 2: Calculate 15% of "A"

"B"

0.15

[Note: this value cannot be changed]

Multiply "A" by 0.15

53,212,311

Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period not counting those issued:

 

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under rule 7.1 or rule 7.4

Note:

• This applies to equity securities, unless specifically excluded - not just ordinary securities

• Include here (if applicable ) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

6,000,000 options(issued 20/12/2012)

2,000,000 options (issued 22/02/2013)

5,000,000 options (issued 08/03/2013)

"C"

13,000,000

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1

"A" x 0.15

Note: number must be same as shown in Step 2

53,212,311

Subtract "C"

Note: number must be same as shown in Step 3

13,000,000

Total ["A" x 0.15] - "C"

40,212,311

[Note: this is the remaining placement capacity under rule 7.1]

Part 2

 

 

Rule 7.1A - Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

"A"

Note: number must be same as shown in Step 1 of Part 1

N/A

Step 2: Calculate 10% of "A"

"D"

0.10

Note: this value cannot be changed

Multiply "A" by 0.10

Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities - not just ordinary securities

• Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• It may be useful to set out issues of securities on different dates as separate line items

"E"

 

 

 

 

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A

"A" x 0.10

Note: number must be same as shown in Step 2

Subtract "E"

Note: number must be same as shown in Step 3

Total ["A" x 0.10] - "E"

 

Note: this is the remaining placement capacity under rule 7.1A

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFLDVVITIIV
Date   Source Headline
24th Oct 20169:56 amRNSQuarterly Report 30 September 2016
24th Oct 20169:08 amRNSOilex Investor Presentation October 2016
24th Oct 20168:58 amRNS2016 Annual Report to Shareholders
24th Oct 20168:33 amRNS2016 AGM Notice of Meeting and Proxy Form
24th Oct 20168:29 amRNS2016 AGM Notice of Meeting
17th Oct 20167:00 amRNSAgreement with GSPC on Cambay-78 Well
29th Sep 20169:03 amRNSAppendix 4G
29th Sep 20169:03 amRNSFinancial Report for year ended 30 June 2016
29th Sep 20168:35 amRNSOilex Corporate Update
25th Aug 20167:00 amRNSExpiry of Unlisted Options
29th Jul 20167:00 amRNSQuarterly Report 30 June 2016
28th Jun 20167:00 amRNSExpiry of Unlisted Options
27th Jun 20167:00 amRNSOilex Investor Presentation June 2016
24th Jun 201610:48 amRNSOilex Corporate Update
10th Jun 201610:17 amRNSAppointment of CFO
8th Jun 20167:00 amRNSZeta Legal Proceedings Settlement
24th May 20168:09 amRNSExecutive Management Changes
18th May 20167:00 amRNSNotification of Major Interest in Shares
17th May 20167:21 amRNSNotification of Major Interest in Shares
6th May 20167:00 amRNSCancellation of Unlisted Options
29th Apr 20168:39 amRNSQuarterly Report 31 March 2016
8th Apr 20167:00 amRNSCommencement of Gas Production from Bhandut Field
18th Mar 20167:00 amRNSOilex Appoints New MD - Jonathan Salomon
18th Mar 20167:00 amRNSAppendix 3Z R Miller
14th Mar 20167:00 amRNSInterim Report 31 December 2015
8th Mar 20167:00 amRNSExpiry of Unlisted Options
1st Mar 20167:00 amRNSZeta Legal Proceedings Update
11th Feb 20167:00 amRNSOilex Strengthens Board with Appointment of NED
11th Feb 20167:00 amRNSAppendix 3X B Lingo
29th Jan 20167:00 amRNSQuarterly Report 31 December 2015
6th Jan 20167:00 amRNSExpiry of Unlisted Options
21st Dec 20157:00 amRNSIndia Operations Update
18th Dec 20157:00 amRNSZeta Legal Proceedings Update
8th Dec 20157:00 amRNSCambay Workover Update
2nd Dec 20159:40 amRNSZeta Legal Proceedings Update
1st Dec 20157:00 amRNSAppendix 3X J Salomon
30th Nov 20157:00 amRNSDirector Appointment
26th Nov 201510:37 amRNSASX Trading Halt
25th Nov 20157:40 amRNSAppendix 3Z J Auld
25th Nov 20157:35 amRNSAppendix 3Z S Bhandari
25th Nov 20157:32 amRNSResults of Annual General Meeting 25 November 2015
25th Nov 20157:00 amRNSCorporate Presentation November 2015
25th Nov 20157:00 amRNSChairman's Address to Shareholders
20th Nov 201512:58 pmRNSAppendix 3Y - S Bhandari
18th Nov 20153:00 pmRNSWithdrawal of Resolution
17th Nov 20151:50 pmRNSIndia Workover Update
13th Nov 20151:00 pmRNSEnd of Trading Halt on ASX
13th Nov 20158:23 amRNSUK Broker
12th Nov 20151:10 pmRNSZeta Update and Legal Proceedings
12th Nov 20157:00 amRNSTrading Halt

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.